Ignite Creation Date:
2024-05-06 @ 3:11 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02225171
Status:
COMPLETED
Last Update Posted:
2023-12-15
First Post:
2014-08-23
Brief Title:
Physicians Experiences With and Attitudes Toward Non-Medical Sex Selection Through Preimplantation Genetic Diagnosis
Sponsor:
National Human Genome Research Institute NHGRI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Physicians Experiences With and Attitudes Toward Non-Medical Sex Selection Through Preimplantation Genetic Diagnosis
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Preimplantation genetic diagnosis PGD is an assisted reproductive technology ART by which embryos created through in vitro fertilization IVF can be screened for genetic conditions or traits before they are implanted into a woman s uterus Within the past few years a controversial non-medical use of PGD has gained recognition as having possible significant ethical implications Non-medical sex selection NMSS describes the use of PGD technology to choose the sex of a child for social as opposed to medical reasons In the US and a select few other countries it is legal to use NMSS for family balancing or the intentional selection of an underrepresented sex to balance a family where the majority of the children are of one sex Proponents of family balancing believe that NMSS is an expression of reproductive autonomy and is ethically acceptable on those grounds Opponents are more likely to cite beneficence toward the existing children and the potential future child and justice resource allocation and access for example as the basis for concerns around NMSS and family balancing specifically In the US and other countries healthcare providers HCPs are often the gatekeepers to this technology There is little research exploring the experiences of HCPs with PGD and NMSS The Moral Experience framework Hunt and Carnevale 2011 is useful for understanding the potential concerns of HCPs as well as their feelings and behaviors evoked by lived and hypothetical experiences around NMSS Also of interest is how HCPs feel that decisions about NMSS are made and their preferences as to how they should be made Finally there is concern that NMSS may be the first in a line of non-medical uses for PGD and that a slippery slope toward what some describe as designer babies will follow We are interested in eliciting the traits that HCPs believe are hypothetically appropriate or inappropriate for PGD and how they make the distinction Interviews with HCPs OBGYNs and reproductive endocrinologists on these topics will be transcribed and subjected to thematic analysis in order to identify common themes An understanding of the experiences and attitudes of this stakeholder population can help clarify current issues at individual societal and global levels and future directions for research and policy
Detailed Description:
Preimplantation genetic diagnosis PGD is an assisted reproductive technology ART by which embryos created through in vitro fertilization IVF can be screened for genetic conditions or traits before they are implanted into a woman s uterus Within the past few years a controversial non-medical use of PGD has gained recognition as having possible significant ethical implications Non-medical sex selection NMSS describes the use of PGD technology to choose the sex of a child for social as opposed to medical reasons In the US and a select few other countries it is legal to use NMSS for family balancing or the intentional selection of an underrepresented sex to balance a family where the majority of the children are of one sex Proponents of family balancing believe that NMSS is an expression of reproductive autonomy and is ethically acceptable on those grounds Opponents are more likely to cite beneficence toward the existing children and the potential future child and justice resource allocation and access for example as the basis for concerns around NMSS and family balancing specifically In the US and other countries healthcare providers HCPs are often the gatekeepers to this technology There is little research exploring the experiences of HCPs with PGD and NMSS The Moral Experience framework Hunt and Carnevale 2011 is useful for understanding the potential concerns of HCPs as well as their feelings and behaviors evoked by lived and hypothetical experiences around NMSS Also of interest is how HCPs feel that decisions about NMSS are made and their preferences as to how they should be made Finally there is concern that NMSS may be the first in a line of non-medical uses for PGD and that a slippery slope toward what some describe as designer babies will follow We are interested in eliciting the traits that HCPs believe are hypothetically appropriate or inappropriate for PGD and how they make the distinction Interviews with HCPs OBGYNs and reproductive endocrinologists on these topics will be transcribed and subjected to thematic analysis in order to identify common themes An understanding of the experiences and attitudes of this stakeholder population can help clarify current issues at individual societal and global levels and future directions for research and policy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 14-HG-N166 | None | None | None |